Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2003
12/11/2003US20030229047 Liquid formulation of decitabine and use of the same
12/11/2003US20030229044 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
12/11/2003US20030229019 Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof
12/11/2003US20030228662 Comprises nucleotide sequences coding tetrodoxin resistant transport protein for diagnosing, prevention and treatment of pain, muscular and cardiac disorders
12/11/2003US20030228360 Combination immediate release controlled release levodopa/carbidopa dosage forms
12/11/2003US20030228355 Precipitation of lipid; fineness particle size
12/11/2003US20030228295 Use of human neural stem cells secreting GDNF for treatment of parkinson's and other neurodegenerative diseases
12/11/2003CA2488270A1 Paramyxoviral vectors encoding antibodies, and uses thereof
12/11/2003CA2487923A1 Monotherapy for the treatment of amyotrophic lateral sclerosis with cyclooxygenase-2 (cox 2) inhibitor(s)
12/11/2003CA2487905A1 Use of cgmp - stimulating compounds
12/11/2003CA2487885A1 Amyotrophic lateral sclerosis treatment with cyclooxygenase-2 inhibitors
12/11/2003CA2487786A1 Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
12/11/2003CA2487688A1 Piperidine derivative, process for producing the same, and use
12/11/2003CA2487679A1 Inhibitors of jak and cdk2 protein kinases
12/11/2003CA2487636A1 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/11/2003CA2487577A1 Implantable polymeric device for sustained release of buprenorphine
12/11/2003CA2487509A1 New salts
12/11/2003CA2487293A1 Use of new etonogestrel esters
12/11/2003CA2486980A1 Attenuated listeria spp. and methods for using the same
12/11/2003CA2486530A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
12/11/2003CA2486191A1 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
12/11/2003CA2485932A1 Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
12/11/2003CA2485871A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
12/11/2003CA2485355A1 The use of milnacipran for the treatment of tension-type headache
12/11/2003CA2484451A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003CA2482838A1 Pyrazole compounds and pharmaceutical compositions containing the compound
12/11/2003CA2482639A1 3-substituted quinuclidines and their use
12/11/2003CA2477261A1 Methods for enhancing motor performance and/or endurance
12/11/2003CA2454654A1 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
12/10/2003EP1369421A1 Pharmaceutical compositions comprising 2,3-Diaryl-pyrazolo[1,5-B]pyridazine derivatives
12/10/2003EP1369417A1 Acridine derivatives
12/10/2003EP1369129A1 Remedies for depression containing ep1 antagonist as the active ingredient
12/10/2003EP1369128A1 Inhibitors of glycoprotein VI and their therapeutic use
12/10/2003EP1369123A1 A health-care product comprising lotus rhizome and process for its preparation
12/10/2003EP1369119A1 Il-12 expression controlling agents
12/10/2003EP1368648A2 Detection of compounds that modulate inflammatory responses
12/10/2003EP1368494A2 Method and test system for identifying substances which protect nerve cells
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368469A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
12/10/2003EP1368458A2 Interferon-alpha induced gene
12/10/2003EP1368381A1 2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368365A2 C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses
12/10/2003EP1368364A1 C2, 8-disubstituted adenosine derivatives and their different uses
12/10/2003EP1368358A1 Isoxazoline derivatives as anti-depressants
12/10/2003EP1368356A2 N-but-3-enyl norbuprenorphine and its use as analgesic
12/10/2003EP1368355A2 Substituted pyrazolopyrimidines and thiazolopyrimidines
12/10/2003EP1368354A1 Modulators of chemokine receptor activity
12/10/2003EP1368350A1 Novel crystal forms of 9-substituted hypoxanthine derivatives
12/10/2003EP1368348A1 Novel 2,5-diazabicyclo(2.2.1)heptane derivatives
12/10/2003EP1368346A1 Substituted benzofuran-2-carboxamides derivatives
12/10/2003EP1368344A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
12/10/2003EP1368343A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists
12/10/2003EP1368342A2 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/10/2003EP1368341A1 Phenyl derivatives 3
12/10/2003EP1368337A2 Piperazine derivatives and their use as 5-ht1b ligands
12/10/2003EP1368336A2 Thiophene substituted amine derivatives as glyt-1 inhibitors
12/10/2003EP1368330A1 Process for the preparation of citalopram
12/10/2003EP1368327A1 Benzo thiadiazine matrix metalloproteinase inhibitors
12/10/2003EP1368325A1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
12/10/2003EP1368324A1 Quinazolines as mmp-13 inhibitors
12/10/2003EP1368322A2 New crystal forms of oxcarbazepine and processes for their preparation
12/10/2003EP1368320A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof
12/10/2003EP1368319A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
12/10/2003EP1368317A1 Tryptase inhibitors
12/10/2003EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators
12/10/2003EP1368312A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368304A1 Prodrugs of excitatory amino acids
12/10/2003EP1368302A1 Novel amino dicarboxylic acid derivatives
12/10/2003EP1368301A1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases
12/10/2003EP1368299A2 Substituted c-cyclohexylmethylamine derivatives
12/10/2003EP1368296A1 Fluorinated trienes and their use as rxr modulators
12/10/2003EP1368253A1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
12/10/2003EP1368094A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
12/10/2003EP1368063A2 Complex of modafinil and cyclodextrin
12/10/2003EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
12/10/2003EP1368051A2 Urocortin-iii and uses thereof
12/10/2003EP1368048A1 Pharmaceutical composition made of cannabis extracts
12/10/2003EP1368047A1 Composition containing asiasari radix extracts for protecting brain cells and improving memory
12/10/2003EP1368043A1 Blood brain barrier modulation using stressed autologous blood cells
12/10/2003EP1368037A2 Estrogen replacement therapy
12/10/2003EP1368033A2 Method and apparatus for treating breakthrough pain
12/10/2003EP1368032A1 Excitatory amino acid receptor antagonists
12/10/2003EP1368031A2 Method of treating of demyelinating diseases or conditions
12/10/2003EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
12/10/2003EP1368023A1 Utilization of buprenorphine in urinary incontinence therapy
12/10/2003EP1368021A1 Carbamate compounds for use in preventing or treating bipolar disorder
12/10/2003EP1368020A2 Method for identifying maxi-k channel blockers
12/10/2003EP1368016A1 Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt
12/10/2003EP1368013A1 Use of a cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications
12/10/2003EP1368008A1 Transdermal therapeutic system for the administration of partial dopamine-d2 agonists
12/10/2003EP1368007A1 Coating and binding agent for pharmaceutical formulations with improved storage stability
12/10/2003EP1367999A2 Water soluble and palatable complexes
12/10/2003EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
12/10/2003EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1228058B1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
12/10/2003EP1185276B1 Isophosphoramide mustard analogs and use thereof
12/10/2003EP1148874B1 Use of anticonvulsant derivatives for treating bulimia nervosa
1 ... 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 ... 1833